Great Oxford Debate at The House of Lords

"This House believes... that commissioners don't have the patient's best interest
at heart"

22nd February 2012, The Cholmondeley Room & Terrace, House of Lords

The word on the street is that PCT Clusters & CCGs are primarily concerned with two things – keeping to their budget and achieving their QIPP financial objectives.

So where do patients’ interests fit in?

If the primary measurement for these objectives is cost, it would not be surprising if the PCT Clusters and CCG commissioners largely focus on cost savings and cost minimisation, rather than improving patient care.

To celebrate its 20th anniversary, the PharmaTimes Great Oxford Debate is moving to London’s House of Lords this year.

To propose this motion:

• Lord Philip Hunt, former health minister
• Roy Lilley, industry commentator
• Eric Low, chief executive, Myeloma UK 

Supporting the case that new Commissioners do have the patient’s best interest at heart is:

• The Rt. Honourable Stephen Dorrell, MP & Chair of the Health Select Committee
• Mike Farrar, chief executive, NHS Confederation
• Anthony McKeever (Mac), former chief executive of Bexley Care Trust.

Limited seating restricts numbers and attendance is by invitation only.

To register your interest in attending click here.

To see the Agenda or to find out more contact Jill Payne: jill@pharmatimes.com 

More about the Great Oxford Debate

Established in 1993, the PharmaTimes Great Oxford Debate is one of UK pharma's premiere calender events.
At one level it promotes, encourages and magnifies debate about an important healthcare issue while at another, it provides a uniquely impressive forum where healthcare executives from all walks of life can meet and freely debate an issue without corporate packs on their backs!

Typically attracting an audience from industry, NHS and Parliament, these annual debates have benefited from some great speakers, including Ministers of Health, Chairmen of Health Select Committees, the FDA and Deputy FDA Commissioners as well as leading NHS consultants, BMA chairmen and wits such as Dr Phil Hammond.

For many companies it is an opportunity to take 'time out' with industry & NHS colleagues in an unrivaled setting, where some of the world’s greatest leaders have spoken.

Check here the highlights from the 2010 Great Oxford Debate  - "This House Believes... that medicines deliver a net saving to the nation". The result? 169 ayes vs. 63 noes.